Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 55,699	$ 99,216
Accounts receivable	1,070	0
Marketable securities	46,361	15,000
Research and development incentive receivable	640	562
Inventory	2,817	0
Prepaid expenses and other current assets	5,588	7,298
Total current assets	112,175	122,076
Property and equipment, net	776	745
Goodwill	17,351	17,351
Intangible asset, net	10,000	0
Right-of-use assets	4,065	5,650
Other assets	2,080	1,436
Assets, Total	146,447	147,258
Current liabilities:
Accounts payable	8,621	8,947
Accrued expenses	23,005	12,816
Current portion of lease liability	1,251	1,099
Total current liabilities	32,877	22,862
Long-term debt, including accretion, net of discount	75,425	54,570
Lease liabilities	1,410	2,612
Warrant liability (Note 5)	13,755	15,683
Other liabilities	831	432
Total liabilities	124,298	96,159
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.001 par value. 10,000,000 shares authorized and no shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	0	0
Common stock, $0.001 par value. 500,000,000 shares authorized as of December 31, 2024 and December 31, 2023, respectively; 170,946,943 and 167,434,595 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	171	167
Additional paid-in capital	537,455	528,956
Accumulated other comprehensive loss	(122)	(119)
Accumulated deficit	(515,355)	(477,905)
Total stockholders’ equity	22,149	51,099
Total liabilities and stockholders’ equity	$ 146,447	$ 147,258